These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11502521)

  • 1. Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy.
    Mulheran M; Degg C; Burr S; Morgan DW; Stableforth DE
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2502-9. PubMed ID: 11502521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patients.
    Mulheran M; Hyman-Taylor P; Tan KH; Lewis S; Stableforth D; Knox A; Smyth A
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2293-9. PubMed ID: 16801404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No hearing loss after repeated courses of tobramycin in cystic fibrosis patients.
    Scheenstra RJ; Heijerman HG; Zuur CL; Touw DJ; Rijntjes E
    Acta Otolaryngol; 2010 Feb; 130(2):253-8. PubMed ID: 19479457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: A study using extended high-frequency audiometry and distortion product otoacoustic emissions.
    Al-Malky G; Suri R; Dawson SJ; Sirimanna T; Kemp D
    Int J Audiol; 2011 Feb; 50(2):112-22. PubMed ID: 21265638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of distortion product OAE generation between a patient group requiring frequent gentamicin therapy and control subjects.
    Mulheran M; Degg C
    Br J Audiol; 1997 Feb; 31(1):5-9. PubMed ID: 9056039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation: Ototoxicity following tobramycin treatment.
    Harruff EE; Kil J; Ortiz MGT; Dorgan D; Jain R; Poth EA; Fifer RC; Kim YJM; Shoup AG; Flume PA
    J Cyst Fibros; 2021 Mar; 20(2):288-294. PubMed ID: 33341407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of nephrotoxicity with prolonged aminoglycoside exposure in patients with cystic fibrosis.
    Saad A; Young MR; Studtmann AE; Autry EB; Schadler A; Beckman EJ; Gardner BM; Wurth MA; Kuhn RJ
    Pediatr Pulmonol; 2020 Dec; 55(12):3384-3390. PubMed ID: 32910553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Otoacoustic emissions for monitoring aminoglycoside-induced ototoxicity in children with cystic fibrosis.
    Stavroulaki P; Vossinakis IC; Dinopoulou D; Doudounakis S; Adamopoulos G; Apostolopoulos N
    Arch Otolaryngol Head Neck Surg; 2002 Feb; 128(2):150-5. PubMed ID: 11843723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin.
    Garinis A; Gleser M; Johns A; Larsen E; Vachhani J
    J Cyst Fibros; 2021 Mar; 20(2):278-283. PubMed ID: 32713806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Relationship between FEV
    Hoff BM; Scheetz MH; Jain M; Cullina JF; Rhodes NJ
    Pharmacotherapy; 2020 Jun; 40(6):584-591. PubMed ID: 32259317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis.
    Al-Malky G; Dawson SJ; Sirimanna T; Bagkeris E; Suri R
    J Cyst Fibros; 2015 Mar; 14(2):248-54. PubMed ID: 25127922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside ototoxicity in cystic fibrosis. Evaluation by high-frequency audiometry.
    McRorie TI; Bosso J; Randolph L
    Am J Dis Child; 1989 Nov; 143(11):1328-32. PubMed ID: 2816859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
    Prescott WA
    Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
    LeCleir LK; Pettit RS
    Pediatr Pulmonol; 2017 Aug; 52(8):1000-1005. PubMed ID: 28440913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients.
    Geyer LB; Menna Barreto SS; Weigert LL; Teixeira AR
    Braz J Otorhinolaryngol; 2015; 81(6):589-97. PubMed ID: 26480907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycoside use in cystic fibrosis: therapeutic strategies and toxicity.
    Prayle A; Smyth AR
    Curr Opin Pulm Med; 2010 Nov; 16(6):604-10. PubMed ID: 20814306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis.
    Garinis AC; Cross CP; Srikanth P; Carroll K; Feeney MP; Keefe DH; Hunter LL; Putterman DB; Cohen DM; Gold JA; Steyger PS
    J Cyst Fibros; 2017 May; 16(3):401-409. PubMed ID: 28238634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous injection of gentamicin and tobramycin without impairment of hearing.
    Dobbs SM; Mawer GE
    J Infect Dis; 1976 Aug; 134 Suppl():S114-7. PubMed ID: 972268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chirp-Evoked Otoacoustic Emissions and Middle Ear Absorbance for Monitoring Ototoxicity in Cystic Fibrosis Patients.
    Garinis AC; Keefe DH; Hunter LL; Fitzpatrick DF; Putterman DB; McMillan GP; Gold JA; Feeney MP
    Ear Hear; 2018; 39(1):69-84. PubMed ID: 28708814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of multiple courses of therapy on aminoglycoside clearance in adult patients with cystic fibrosis.
    Alghanem S; Paterson I; Touw DJ; Thomson AH
    J Antimicrob Chemother; 2013 Jun; 68(6):1338-47. PubMed ID: 23435691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.